Status: current, Defined. Date: 31-Jan 2016. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3299137010 | Parenteral form belimumab (product) | en | Fully specified name | Inactive | Initial character case insensitive | SNOMED CT core |
| 3299671019 | Parenteral form belimumab | en | Synonym | Inactive | Initial character case insensitive | SNOMED CT core |
| 3488733010 | Product containing belimumab in parenteral dosage form (medicinal product form) | en | Fully specified name | Inactive | Case insensitive | SNOMED CT core |
| 3497955011 | Belimumab in parenteral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3497956012 | Product containing belimumab in parenteral dosage form | en | Synonym | Inactive | Case insensitive | SNOMED CT core |
| 3708720010 | Belimumab-containing product in parenteral dose form | en | Synonym | Active | Case insensitive | SNOMED CT core |
| 3708721014 | Product containing belimumab in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Belimumab-containing product in parenteral dose form | Is a | Product manufactured as parenteral dose form | true | Inferred relationship | Some | ||
| Belimumab-containing product in parenteral dose form | Is a | Belimumab-containing product | true | Inferred relationship | Some | ||
| Belimumab-containing product in parenteral dose form | Has active ingredient | Belimumab | true | Inferred relationship | Some | 1 | |
| Belimumab-containing product in parenteral dose form | Has manufactured dose form | Parenteral dose form | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Belimumab only product in parenteral dose form | Is a | True | Belimumab-containing product in parenteral dose form | Inferred relationship | Some | |
| Belimumab 400 mg lyophilised powder for solution for injection vial | Is a | False | Belimumab-containing product in parenteral dose form | Inferred relationship | Some | |
| Belimumab 120 mg lyophilised powder for solution for injection vial | Is a | False | Belimumab-containing product in parenteral dose form | Inferred relationship | Some |
This concept is not in any reference sets